Press release
Number of shares and votes in Oncopeptides
STOCKHOLM — July 31, 2023 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases, today announces that the number of shares and votes in Oncopeptides has changed as a result of the company’s issue of 219,843 new class C shares in accordance with the shareholder program Board SHP 2023 adopted by the annual general meeting on May 25, 2023.
Before the share issue, the total number of outstanding shares in Oncopeptides amounted to 94,309,267 and the total number of votes in Oncopeptides amounted to 90,762,720.7. As a result of the share issue, the number of outstanding shares in Oncopeptides has increased by 219,843 shares, corresponding to 21,984.3 votes. As of today, the total number of outstanding shares in Oncopeptides amounts to 94,529,110 shares, of which 90,368,660 are ordinary shares and 4,160,450 are class C shares. The number of votes in Oncopeptides as of today amounts to 90,784,705. The share capital has increased by SEK 24,427.000993 from SEK 10,478,807.870004 to SEK 10,503,234.870997.